Dr. Gordon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1565 Rockmont Cir
Boulder, CO 80305Phone+1 303-517-6212Fax+1 303-494-4103
Education & Training
Harvard Medical SchoolClass of 1983
Certifications & Licensure
CO State Medical License 1985 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 8 citationsSafety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in AdultsJoseph J. Eiden, Gilad Gordon, Carlos Fierro, Renee Herber, Roger Aitchison
Vaccines. 2021-11-24 - 5 citationsPhase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumorsKyriakos P. Papadopoulos, Nehal Lakhani, Gerald Steven Falchook, Gosia Riley, Johan Baeck
Cancer Immunology, Immunotherapy. 2021-03-01 - 66 citationsSafety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 ...Chukiat Sirivichayakul, Elizabeth A. Barranco-Santana, Inés Esquilin-Rivera, Helen M. L. Oh, Marsha Raanan
The Journal of Infectious Diseases. 2016-05-15
Press Mentions
CytRx Partners with Oncology Development Expert to Advance LADR PlatformApril 20th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
